In a country where cancer incidence is rising and access to advanced treatment remains uneven, such steps matter... Feb 07
In a country where cancer incidence is rising and access to advanced treatment remains uneven, such steps matter.... Feb 03
Latest FDA news... Feb 08
Eprenetapopt indicated for the treatment of TP53 Mutant Acute Myeloid Leukemia (AML)... Dec 02
... Oct 17
-Advertisements-